153 related articles for article (PubMed ID: 7423193)
1. Genotoxicity of the antihypertensive drugs hydralazine and dihydralazine.
Williams GM; Mazue G; McQueen CA; Shimada T
Science; 1980 Oct; 210(4467):329-30. PubMed ID: 7423193
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro genotoxicity of three antihypertensive hydrazine derivatives (hydralazine, dihydralazine, and endralazine).
de Flora S; Zanacchi P; Bennicelli C; Camoirano A; Cavanna M; Sciabà L; Cajelli E; Faggin P; Brambilla G
Environ Mutagen; 1982; 4(5):605-19. PubMed ID: 7140679
[TBL] [Abstract][Full Text] [Related]
3. Studies on the mutagenic activity of hydralazine and dihydralazine in Salmonella typhimurium strains differing in expression of antioxidant genes.
Chłopkiewicz B
Toxicol Lett; 1999 Nov; 110(3):203-7. PubMed ID: 10597029
[TBL] [Abstract][Full Text] [Related]
4. Influence of metabolic activation on the induction of micronuclei by antihypertensive drugs in L929 cells.
Chłopkiewicz B
Arch Toxicol; 2001 Feb; 74(12):794-8. PubMed ID: 11305783
[TBL] [Abstract][Full Text] [Related]
5. Genotoxicity of hydrazino-phtalazine antihypertensive drugs assessed by an in vitro micronucleus assay.
Chłopkiewicz B
Acta Pol Pharm; 1996; 53(5):361-4. PubMed ID: 9415211
[TBL] [Abstract][Full Text] [Related]
6. Genetic effects of binazine and hydralazine in vitro and in vivo.
Chłopkiewicz B; Ejchart A; Marczewska J
Acta Pol Pharm; 1995; 52(1):31-3. PubMed ID: 8960236
[TBL] [Abstract][Full Text] [Related]
7. DNA-damaging activity in vivo and bacterial mutagenicity of sixteen hydrazine derivatives as related quantitatively to their carcinogenicity.
Parodi S; De Flora S; Cavanna M; Pino A; Robbiano L; Bennicelli C; Brambilla G
Cancer Res; 1981 Apr; 41(4):1469-82. PubMed ID: 7214329
[TBL] [Abstract][Full Text] [Related]
8. Mutagenicity of hydralazine in mammalian cells and bacteria.
McQueen CA; Way BM; Queener SM
Toxicol Appl Pharmacol; 1993 Jan; 118(1):135-8. PubMed ID: 8430421
[TBL] [Abstract][Full Text] [Related]
9. Genetic toxicity of several antihypertensive drugs possessing a hydrazine group.
Kitamura J; Mori H; Sugie S; Kawai K
Res Commun Chem Pathol Pharmacol; 1985 Sep; 49(3):415-22. PubMed ID: 4059657
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of mutagenicity and genotoxicity induced by dihydralazine.
Chłopkiewicz B; Ejchart A; Marczewska J
Acta Biochim Pol; 1995; 42(3):291-5. PubMed ID: 8588478
[TBL] [Abstract][Full Text] [Related]
11. Mutagenicity of B(a)P in the presence of some hydralazine derivatives.
Gasiorowski K; Szyba K; Sawicka J; Gulanowski B
Pol J Occup Med Environ Health; 1993; 6(4):383-9. PubMed ID: 8019200
[TBL] [Abstract][Full Text] [Related]
12. Acetylation and its role in the mutagenicity of the antihypertensive agent hydralazine.
Lemke LE; McQueen CA
Drug Metab Dispos; 1995 May; 23(5):559-65. PubMed ID: 7587931
[TBL] [Abstract][Full Text] [Related]
13. Assay of 855 test chemicals in ten tester strains using a new modification of the Ames test for bacterial mutagens.
McMahon RE; Cline JC; Thompson CZ
Cancer Res; 1979 Mar; 39(3):682-93. PubMed ID: 371791
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo testing of hydralazine genotoxicity.
Martelli A; Allavena A; Campart GB; Canonero R; Ghia M; Mattioli F; Mereto E; Robbiano L; Brambilla G
J Pharmacol Exp Ther; 1995 Apr; 273(1):113-20. PubMed ID: 7714756
[TBL] [Abstract][Full Text] [Related]
15. Reliability of the hepatocyte primary culture/DNA repair test in testing of coded carcinogens and noncarcinogens.
Williams GM; Laspia MF; Dunkel VC
Mutat Res; 1982 Oct; 97(5):359-70. PubMed ID: 7144803
[TBL] [Abstract][Full Text] [Related]
16. Dihydralazine therapy and acetylator phenotype.
Iisalo E; Laine T; Lehtonen A; Sellman R
Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):119-24. PubMed ID: 429082
[TBL] [Abstract][Full Text] [Related]
17. Plasma concentrations and pharmacokinetics of dihydralazine after single oral doses to human subjects.
Waller AR; Chasseaud LF; Taylor T; Darragh A; O'Kelly DA
Biopharm Drug Dispos; 1979; 1(2):59-64. PubMed ID: 552862
[TBL] [Abstract][Full Text] [Related]
18. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
Simmon VF
J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
[TBL] [Abstract][Full Text] [Related]
19. Genotoxicity of a variety of mycotoxins in the hepatocyte primary culture/DNA repair test using rat and mouse hepatocytes.
Mori H; Kawai K; Ohbayashi F; Kuniyasu T; Yamazaki M; Hamasaki T; Williams GM
Cancer Res; 1984 Jul; 44(7):2918-23. PubMed ID: 6722817
[TBL] [Abstract][Full Text] [Related]
20. DNA damage and repair tests for the detection of genotoxic agents.
Williams GM
Food Addit Contam; 1984; 1(2):173-8. PubMed ID: 6536528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
